![]() , a clinical-stage company, develops therapeutics to treat diseases in areas of high unmet need. This would suggest that Synthetic Biologics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns). The market (NYSE average) beta is 1, while Synthetic Biologics's is 1.3887. volatility (beta: 1.00) Low Highīeta is a measure of a share's volatility in relation to the market. A popular way to gauge a stock's volatility is its "beta". Over the last 12 months, Synthetic Biologics's shares have ranged in value from as little as $0.575 up to $4.394. Synthetic Biologics share price volatility However, indirectly, the new 900% higher share price could have impacted the market appetite for Synthetic Biologics shares which in turn could have impacted Synthetic Biologics's share price. This wouldn't directly have changed the overall worth of your Synthetic Biologics shares – just the quantity. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. Synthetic Biologics's shares were split on a 1:10 basis on 24 July 2022. Have Synthetic Biologics's shares ever split? ![]() We're not expecting Synthetic Biologics to pay a dividend over the next 12 months. TTM: trailing 12 months Synthetic Biologics share dividends ![]() Synthetic Biologics financials Gross profit TTM ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |